• AusCann has raised approximately A$1.9m via a Share Purchase Plan (SPP) and will issue approximately 1.8m new shares
• The SPP followed a share placement to institutional and sophisticated investors which raised approximately A$33.4m
• Proceeds of the placement and SPP will be used to fund clinical studies, R&D, the expansion of the Company’s Australian and Chilean operations, the medical outreach program and for working capital
Thursday, 9 August 2018 – Leading medical cannabis company AusCann Group Holdings Limited (ASX:AC8) (“AusCann” or “the Company”) is pleased to provide the results of its recent Share Purchase Plan (“SPP”).
For further information please download PDF attached:
Download this document